ArticleMolecular neurobiology2025
Golden Oyster Mushroom Extract Ameliorates Oxidative Stress-Induced Cell Death in Neurons and Scopolamine-Induced Cholinergic System Impairment in Mice.
Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Sustainable mushroom cultivation: a scoping review on circular bioeconomy practices and food system implications.World journal of microbiology & biotechnology · 2026Article
- Transcranial vibrotactile stimulation enhances hippocampal cholinergic signaling and memory through frequency-dependent mechanotransduction.Scientific reports · 2026Article
- Phenolic content and biological activities of Lenzites betulina extracts obtained by ultrasonic-assisted optimization approaches.Scientific reports · 2026Article
- Ergothioneine-rich water extracts ofFrontiers in nutrition · 2026Article
- Administration of Cilostazol Mitigates Learning and Memory Disturbance in a Rat Model of Amnesia by Modifying Cholinergic Function and Neuroinflammation.Molecular neurobiology · 2025Article
- Edible mushrooms as emerging biofactories for natural therapeutics and oral biopharmaceutical delivery.Frontiers in fungal biology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Impaired cholinergic system is an important therapeutic target to develop drugs against Alzheimer's disease (AD), as cholinergic signal transduction is associated with the memory, learning, and behavior of an individual. Acetylcholine (ACh) is an important neurotransmitter and is degraded by an enzyme, acetylcholinesterase (AChE), blocking neuronal signal transmission, which leads to amnesia or memory loss. Oxidative stress (OS) also worsens AD pathology by damaging lipids, proteins and DNA of the neuronal cells, leading to neuronal cell death. Golden oyster mushroom (GOM), an edible mushroom native to the regions of Japan, Korea, Russia, and China, has been reported to possess several bioactivities. However, there is no study reported till date, studying the anti-amnesic properties of GOM. The objectives of this study were to assimilate the in vitro neuroprotective and in vivo anti-amnesic properties of GOM. The GOM at 0.1, 0.5, 1, 5, and 10 mg/ml was nontoxic and was able to prevent H
Indexed as
Identifiers
40682719What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.